India  

Is it worth giving COVID jabs to 12-year-olds? Vaccine experts now face an ethical dilemma

Sky News Friday, 4 June 2021
The clinical trial results released on Friday by the Medicines and Healthcare products Regulatory Agency (MHRA) show once again just how good the Pfizer-BioNTech vaccine is.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Rising Energy Costs Expected to Drive Inflation to an All-Time High in the UK [Video]

Rising Energy Costs Expected to Drive Inflation to an All-Time High in the UK

Rising Energy Costs, Expected to Drive Inflation , to an All-Time High in the UK. 'The Independent' reports that new data from the Office for National Statistics will paint a clear picture of the , cost of living crisis , experienced by households across the UK. Officials at the Bank of England expect inflation to rise over 10% in 2022. According to 'The Independent,' forecasts predict 2022 will see the highest one-year increase since the Consumer Price Index began keeping records in 1998. April's rise in prices was reportedly driven by a surge in energy bills, which went up 54% for an average household. A survey by consultancy firm McKinsey found that rising inflation was the largest concern felt by respondents in the UK, followed by the war in Ukraine and the COVID pandemic. A survey by consultancy firm McKinsey found that rising inflation was the largest concern felt by respondents in the UK, followed by the war in Ukraine and the COVID pandemic. 'The Independent' reports that inflation figures could affect interest rates set by the Bank of England's, Monetary Policy Committee. If confirmed, this would place huge pressure on the Bank of England to continue raising interest rates at upcoming meetings, Matthew Ryan, Analyst at financial services firm Ebury, via 'The Independent'. Communications from the MPC have turned increasingly dovish and largely muddled in recent weeks, although we think that upcoming inflation prints will likely force the bank’s hand, Matthew Ryan, Analyst at financial services firm Ebury, via 'The Independent'. On May 16, the Bank's governor, Andrew Bailey, said that the high price of global energy and goods will impact consumer demand and potentially increase unemployment. On May 16, the Bank's governor, Andrew Bailey, said that the high price of global energy and goods will impact consumer demand and potentially increase unemployment. The main driver of inflation and what brings it down is the very big, real income shock which is coming from outside forces and, particularly, energy prices and global goods prices, Andrew Bailey, Bank of England Governor, via 'The Independent'

Credit: Wibbitz Top Stories    Duration: 01:31Published

Scientists get £15m boost in fight against fatal respiratory illness 'black hole'

Goutam Das doesn't remember much about his five weeks in intensive care with COVID-19.
Sky News
Covid-19 in North Korea: Military ramps up response effort as virus surges [Video]

Covid-19 in North Korea: Military ramps up response effort as virus surges

Credit: FRANCE 24 English    Duration: 01:32Published
Covid-19 update: India logs 1,569 new cases and 19 deaths in last 24 hours | Oneindia News [Video]

Covid-19 update: India logs 1,569 new cases and 19 deaths in last 24 hours | Oneindia News

According to the Union Health ministry's data, India added 1,569 Covid cases and 19 Covid-related deaths in the last 24 hours. #CovidIndia #Covid19 #CovidCases #CoronaDeaths

Credit: Oneindia    Duration: 01:35Published

Covid-19: India reports 1,569 new cases, 19 deaths in last 24 hours; active cases today 16,400

India's active case tally now stands at 16,400, seeing a dip of 917 cases from the previous day, the Union health ministry bulletin stated. The current recovery..
IndiaTimes

BioNTech BioNTech German biotechnology company

Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says [Video]

Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says

Booster Shots in Children Ages 5–11 , Increase Omicron Antibodies, Pfizer Says. NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14. NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14. Given half a year after the initial series of two doses, a booster shot of the Pfizer-BioNTech vaccine increased antibody levels sixfold. In Pfizer's clinical trial, 140 children ages 5 through 11 received a booster shot. According to NBC News, data has not yet been made available to independent researchers for review. In the era of Omicron, booster doses of COVID vaccines have been hit and miss. In adults, a booster dose of Pfizer's vaccine wanes dramatically after four months. Health experts say the same trends are likely to occur in children. For adults, Pfizer's vaccine is 30 micrograms per dose. For children, vaccines are 10 micrograms per dose. Earlier this year, New York Department of Health researchers found Pfizer's vaccine to offer minimal protection against infection in children. But according to NBC, the CDC later said two doses in children offered ample protection against severe infections. But according to NBC, the CDC later said two doses in children offered ample protection against severe infections

Credit: Wibbitz Top Stories    Duration: 01:30Published

Pfizer Pfizer American multinational pharmaceutical corporation

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA [Video]

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Pfizer’s COVID Booster Shot , for 5 to 11 Year Olds, Authorized by FDA. NBC News reports on May 17, the Food and Drug Administration (FDA)... … announced it had authorized Pfizer-BioNTech's coronavirus booster dose for 5 to 11 year olds. The FDA says eligible recipients of a booster dose could receive the extra shot starting five months after their initial two-dose series. Per NBC News, Pfizer's booster shot for 5 to 11 year olds is 10 micrograms ... . ... a third of the dosage given to citizens 12 and older. Following the FDA's ruling, it is now up to the Centers for Disease Control and Prevention (CDC) to recommend how to implement boosters for the age group. CDC data shows less than one third of 5 to 11 year olds in the United States have recieved the primary series of a COVID-19 vaccine. Experts say booster shots offer better protection against the omicron strain and its associated subvariants. The CDC's Advisory Committee on Immunization Practices will reportedly discuss booster shots on May 19. Dr. Rochelle Walensky, the Director of the CDC, should have her final recommendation following the committee's discussion

Credit: Wibbitz Top Stories    Duration: 01:30Published
Pfizer's First Quarter Profits Blast Past 2022 Forecast [Video]

Pfizer's First Quarter Profits Blast Past 2022 Forecast

Pfizer's First Quarter , Profits Blast Past, 2022 Forecast. ABC reports that Pfizer's COVID-19 vaccine and treatment sales helped propel the pharmaceuticals company beyond Wall Street's first quarter expectations. . Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter. . Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter. . The vaccine has remained Pfizer's top selling product for almost the last year. . The drugmaker's pill treatment Paxloid reportedly added an additional $1.5 billion to the company's sales. . ABC reports that Pfizer's, profits grew 61% , in the first quarter. . On May 3, the company posted a net income of $7.86 billion and first quarter adjusted earnings of $1.62 per share. . The results easily exceeded the $1.49 increase predicted by industry analysts. . Compared to the same time last year, the company's revenue skyrocketed 77% , to reach $25.66 billion. . According to ABC, the drugmaker expects the company's total revenue in 2022 to reach between $98 billion and $102 billion. . Pfizer's COVID vaccine launched late in 2020 and quickly became the company's top selling product by the second quarter of 2021. In December of 2021, Pfizer's stock reached an all-time high of $61.71 per share.

Credit: Wibbitz Top Stories    Duration: 01:31Published
Biden Administration Secures 20 Million Courses of Paxlovid [Video]

Biden Administration Secures 20 Million Courses of Paxlovid

Biden Administration Secures , 20 Million Courses of Paxlovid. Biden Administration Secures , 20 Million Courses of Paxlovid. CNN reports that on April 25, a senior administration official said , 20 million treatment courses of Pfizer's antiviral COVID pill have been secured for the United States to purchase. 100,000 treatment courses will be provided to pharmacies per quarter as need and uptake are observed. . A treatment course of Paxlovid consists of taking three pills twice a day for five days. CNN reports that Pfizer released data last year showing that its antiviral COVID pill reduced the risk of hospitalization or death by 89% if taken within a few day of exhibiting symptoms. Paxlovid first became authorized by the FDA at the end of December. And there were very, very few pills around. The administration worked incredibly hard to both increase production and acquisition, and the good news is we’ve made really substantial progress, Dr. Ashish Jha, White House COVID-19 Response Coordinator, to NPR. Now we’ve got to turn those pills into prescriptions and into the things that patients can get so that they can get better if they get infected. We have a big set of efforts that we have been working on and launching, and we’re going to be doing a lot more this week, Dr. Ashish Jha, White House COVID-19 Response Coordinator, to NPR. On April 26, the administration is expected to announce expanded access to the pills via its federal antiviral pharmacy program. It is estimated that over 30,000 locations may provide free treatments in the future through the test-to-treat initiative. While the purchase of a significant amount of treatment courses has been secured thus far. CNN reports that the administration "will not be able to purchase more" unless it secures further funding from Congress

Credit: Wibbitz Top Stories    Duration: 01:30Published
Moderna Working on Vaccine Booster That Targets the Omicron Variant [Video]

Moderna Working on Vaccine Booster That Targets the Omicron Variant

Moderna Working on , Vaccine Booster That Targets, the Omicron Variant. The Associated Press reports that Moderna is developing an updated COVID-19 booster that offers protection against the omicron variant. On April 19, the pharmaceutical company released data suggesting that work on the updated booster was making progress. Prior to the emergence of omicron, Moderna had been developing a booster with added protection against the beta variant of coronavirus. According to the company, people who received that specific booster produced more antibodies capable of fighting a number of variants. AP reports that the omicron variant is able to more easily slip past the immune system's defenses than the original coronavirus. According to health officials, distributing boosters every few months does not present a practical solution to the mutating virus. As a result, Moderna and its rival Pfizer are testing "bivalent" shots which mixes each company's original vaccine with an updated omicron version. . As a result, Moderna and its rival Pfizer are testing "bivalent" shots which mixes each company's original vaccine with an updated omicron version. . Moderna's bivalent shot reportedly includes 32 variant mutations of the coronavirus. Studies on the new bivalent shots are currently underway in the United States and Britain. . Results from the studies are expected by late June

Credit: Wibbitz Top Stories    Duration: 01:30Published

Related news from verified sources

Israel: Covid stands between Promised Land and 40 Manipuris

For over a hundred Bnei Menashe Jews from Manipur going to Israel, Covid-19 proved a damper. On Monday, hours before checking out from their Karol Bagh hotel for...
IndiaTimes

Common post COVID symptoms, as per new study

Apart from the dangers of coronavirus symptoms, post COVID complications have also posed a great deal of threat to our physical and mental well-being. While...
IndiaTimes

Thiruvananthapuram: This doctor quit a private job to be a Covid team volunteer

A few days ago, Dr Muhammad Yazin and his team at the Covid control room run by Vattiyoorkavu MLA V K Prasanth broke into a house. Their intentions, however,...
IndiaTimes